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Abstract
Adolescents and young adults (AYAs) with CKD or end-stage
kidney disease (ESKD) have unique medical, dental, psychosocial, neurocognitive, and academic needs and require
close interdisciplinary collaboration to optimize their care.
The etiology of CKD in AYAs is diverse compared to older
adults. With their continuously improved survival, AYAs
must start preparation for health-care transition (HCT) from
pediatric- to adult-focused health care in the pediatric setting and it must continue at the adult-focused setting, given
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that their brain maturation and self-management skill acquisition occur until their mid-20s. While the growth and physical maturation of most visible body parts occur before 18
years of age, the prefrontal cortex of the brain, where reasoning, impulse control, and other higher executive functions
reside, matures around 25 years of age. The HCT process
must be monitored using patient- and caregiver-measuring
tools to guide interventions. The HCT process becomes more
complex when patients and/or caregivers have a language
barrier, different cultural beliefs, or lower literacy levels. In
this article, we discuss the unique comorbidities of pediatriconset CKD/ESKD, provide information for a planned HCT
preparation, and suggest interdisciplinary coordination as
well as cultural and literacy-appropriate activities to achieve
optimal patient outcomes.
© 2021 S. Karger AG, Basel
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Cognitive impairment/poor executive function
ADHD/learning abnormalities, mood disorders (> anxiety
than depression) and risk behaviors
Dental abnormalities
Cardiovascular disease
Gastrointestinal disturbances
Fertility issues (> in males with congenital anomalies).
Menstrual irregularities and endometriosis in females
Metabolic bone disease, metabolic acidosis
Surgical issues: dialysis access, urological procedures
and orthopedic issues
Anemia
Low employment/self-esteem/health-related quality of life,
non-adherence, poor self-management
& decreased lifespan

Fig. 1. Comorbidities of pediatric-onset CKD or ESKD. ESKD, end-stage kidney disease; HRQoL, health-related

quality of life.

Chronic Kidney Disease/End-Stage Kidney Disease in
Adolescents and Young Adults

Prevalence, Etiology and Survival
The prevalence of CKD in this age group is not well
defined, and there are substantial regional, socioeconomic, and ethnic differences as well as undiagnosed cases in
developing countries [1–3]. The prevalence of end-stage
kidney disease (ESKD) in children and adolescents is 55–
60 per million of age-related population [4] but it is rising,
due to an increase of congenital anomalies of the kidneys
and urinary tract (CAKUT) and cancer survival [5]. The
etiology of CKD/ESKD in adolescents and young adults
(AYAs) varies by age with predominantly CAKUT in
younger patients and glomerular conditions in older patients [6–8]. AYAs with ESKD have a 10-year survival of
>85% [9] and health-care transition (HCT) preparation
from pediatric- to adult-focused care and from parentdirected to health self-management must take place, to
ensure optimal patient outcomes.
Unique Comorbidities
AYAs with CKD/ESKD have unique comorbidities
(Fig. 1; Table 1) that create specific challenges for patients, families, and providers as they have to manage the
burden of care including: polypharmacy [10], procedures
Transition to Adult-Focused Health care

(enteral feeding, catheterizations, injections – growth
hormone – or erythropoietin-stimulating agents – or dialysis), special diets, academic challenges, multiple medical appointments, and increase health-care utilization
(surgeries, admissions, or emergency department visits)
[11]. Other comorbidities include cardiovascular complications [12, 13], growth, mineral bone disorders [14],
anemia, reproductive abnormalities, and dental conditions. These patients need close interdisciplinary collaboration to optimize their care.
Cognitive Impairment, ADHD, and Academic and
Psychological Issues
AYAs with CKD/ESKD are more likely to have cognitive deficits and learning disabilities such as poor executive function and short attention span, and these are directly related to the disease duration [15, 16]. ADHD is
highly prevalent in patients with pediatric-onset CKD/
ESKD and often is undiagnosed [17]. It is essential to recognize their learning challenges, ADHD and school absenteeism, and facilitate remediation [18].
In addition, social interactions with their peers and
teachers may place them at risk for being labeled as “different” and/or bullying. Failure to recognize these challenges may result in behavioral and affective disorders. It
is well known that emotional health is associated with
Blood Purif 2021;50:684–695
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Table 1. Comorbidities of pediatric-onset CKD or ESKD, and HCT preparation
System

Manifestations/issues

Management to avoid complications

Cardiovascular

Hypertension or volume overload

Aggressive blood pressure control by height percentile if younger than 13
years of age or <130/80 if older than 13 years of age. Monitor cardiac function.
If applicable, encourage fluid restriction

Sodium

Retention in patients with glomerular
conditions

Fluid restriction and diuretics (if applicable). Thiazides in the early stages of
CKD and loop diuretics in later stages of CKD

Wasting in patients with CAKUT and is
associated with poor growth

Salt supplementation from 1 to 5 mEq/kg/day

Hyperkalemia

Restrict potassium-rich food

Hypokalemia

Supplement potassium and constant monitoring to avoid hyperkalemia

Hematological

Anemia

Maintain age-appropriate hemoglobin (target for average of 12.0 mg/dL)

Mineral bone
abnormalities

Metabolic bone disease

Vitamin D/calcium supplementation, phosphate binders. Avoid
hyperparathyroidism, high or low bone turnover. Keep bone mineral labs in
normal ranges for age to optimize growth

Acid-base balance

Metabolic acidosis

Bicarbonate supplementation

Growth

Short stature

Optimize acidosis, metabolic bone disease, and anemia. If possible, prescribe
growth hormone supplementation

Dyslipidemia

Abnormal lipid panel

Evaluate need for fibrates or krill oil. Consider diet and lipid-lowering agents
in heterozygous familial hypercholesterolemia

Dental issues

Teeth, enamel, gum, and salivary issues

Early referral to dental services. Avoid medications that affect dental health

Psychoeducation

Poor academic performance

Foster interdisciplinary collaboration with social workers and educational
providers. Create care plans and facilitate school adaptation

Anxiety

Use screening tools in the clinic such as GADS Survey, RCADS child/RCADSparent, and PHQ-9 Surveys. Provide behavioral health services to the patients.
Refer to psychological team

Depression

Provide behavioral health services and medical treatment

HRQoL

Individual conception of happiness and
wellness

Use validated questionnaires such as PROMIS or PedsQLfocused in
adolescents and young adults with CKD. Identify areas of improvement for
the patient

Treatment adherence

Failure or success in treatment with
biological and clinical manifestations

Educational program about disease and complications, importance of
medications; work with parents with reminders and multidisciplinary
strategies

Diet adherence

Failure or success in treatment with
biological and clinical manifestations

Educational program importance of dietary restrictions, and their
specifications, work among family and dietitians to accommodate a suitable
diet (budget and cultural/religious restrictions)

Appointment adherence

Failure or success to keep a specific number
of appointments and failure or success to
communicate with the health-care
providers

Coordinate visits with multiple providers. If electronic health records
available, encourage the patient/caregiver to use the patient portal for
communication. Use telemedicine when possible

Disease-specific and
nutrition education
material

Available patient education material at high
literacy level

Low-literacy tools available at the following website: www.med.unc.edu/
transition. Create or adapt current patient education material to the different
developmental ages with a 4th-grade literacy level

Potassium

Cognitive impairment
Academic issues
Mood disorders

ESKD, end-stage kidney disease; HCT, health-care transition; CAKUT, congenital anomalies of the kidneys and urinary tract.
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medical consequences that limit their health management and school performance. Hence, it is essential to
inform the school personnel (counselors, teachers, social
workers, and school nurses) about the academic, physical,
and emotional effects of CKD/ESKD. Supporting these
students in their academic performance and integrating
them with their peers becomes extremely important.
Communicating often with the academic team will overcome many of the barriers while maximizing learning opportunities.
Unfortunately, most AYAs do not like to disclose their
health conditions [19]. Health-care providers must discuss disclosure issues in a private setting and be proactive
in addressing patients’ concerns. A letter can be given to
the patient and parent to be delivered to the school system, stressing the point about unrecognized learning disabilities, particularly if their condition presented at
younger ages [20]. Teachers need to implement technical
and didactic activities that encourage the patients’ participation. Teachers need to prepare, update, and make an
additional effort to recognize what their students require
(including an individualized education plan), making use
of all available pedagogical resources to help them promote a better academic performance, adaptation and integration of the student into the group where their participation is appreciated and recognized. Flexibility, organization, and distribution of content are reasonable
adjustments that should be applied, according to the student’s academic progress. In addition, the educator recommendations generate favorable environments for peer
support and interrelation, maintaining an optimal balance for the development of socioemotional resilience
[21].
Psychological Issues
Anxiety and depression are highly prevalent among
pediatric CKD patients and often are associated with a
history of maternal depression and anxiety, sometimes
even during pregnancy for prenatally diagnosed conditions [22]. Mood disorders can affect as many as 2/3 of
patients, especially in families with lower socioeconomic
status [22]. In the CKD cohort, >25% of the patients have
internalizing problems, attention problems and poor
adaptive skills, persistent hypertension-associated attention problems, and resulting behavioral symptoms [23].
Health-Related Quality of Life
Even with mild CKD, children report worse overall
health-related quality of life, physical, school, emotional,
and social functioning in comparison with healthy chilTransition to Adult-Focused Health care

dren [24]. Early intervention to improve linear growth
and to address school functioning difficulties is recommended [24]. The ramifications of these difficulties are in
part responsible for the substantial problems in early
adulthood [25]. The longer the duration of ESKD, the
lower the adult health-related quality of life. Former pediatric ESKD patients often cannot find a partner, live
independently, or achieve gainful employment. AYAs
with CKD/ESKD and low parental educational levels require optimized educational, psychologic, and social support to reach the educational level of their peers. This support should be maintained during adulthood to help
them integrate into the workforce and build a family [26].
The negative impact of short stature cannot be emphasized enough [27].
Adherence
Adhering to the often complex and intense requirements of CKD/ESKD treatment is challenging. Adolescents and parents feel emotional attachment to the pediatric unit and use the support system as a tool to adherence. Once in adult care, adolescents feel out of place
among the older patients, overwhelmed by the environment and the perceived lack of attention from health professionals [28]. This often results in even worse adherence
and subsequent graft loss.
Dental Conditions in Pediatric-Onset CKD/ESKD
Dental and oral health is understudied in pediatric patients with CKD/ESKD. They can have decreased salivary
flow (related to fluid restriction or medication side effects), abnormal saliva [29], stomatitis, gingivitis and parotitis [30, 31], altered salivary composition [32], and
enamel hypoplasia. Amlodipine [33] and cyclosporine
[34] are associated with substantial gingival hyperplasia.
The oral pathology in CKD/ESKD may affect deciduous
and/or permanent teeth and may worsen with longer disease duration and/or genetic conditions. Of interest, a
systematic review of the literature revealed that dental
caries is lower among pediatric patients with CKD compared to healthy controls, likely related to the effects of
uremia [35].
Cardiovascular Issues
Cardiovascular complications are highly prevalent
among pediatric CKD patients and form the major cause
of premature death [12, 14, 36, 37]. The mechanisms are
multifactorial, including end-organ damage from hypertension [37], volume overload [38], increased peripheral
resistance [38] and may be due to elevated fibroblast facBlood Purif 2021;50:684–695
DOI: 10.1159/000513520
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tor 23 [39–41], cardiac stunning during dialysis with intradialytic hypotension [42, 43], and other factors. More
recently, derangements of essential and toxic trace elements have been recognized. [44–47]. The changes are
not limited to the heart, but there is also a high prevalence
of aortic dilation [13, 48, 49]. It will be important to pay
more attention to these issues to prolong the long-term
survival of these patients.
Gastrointestinal and Nutrition Issues
Constipation is highly prevalent and may be related to
high output kidney failure in CAKUT patients, structural
problems such as Prune-belly syndrome, or neurological
problems, such as in spina bifida patients. Cachexia or
protein energy-wasting is common in pediatric patients
with CKD/ESKD and thought to be related to systemic
inflammation, endocrine disturbances, abnormal neuropeptide signaling, and poor nutritional intake [50]. These
patients also often have delayed gastric emptying, resulting in changes of their oral glucose tolerance testing.
Thinness has also been associated with aortic dilation
[48]. Aggressive enteral nutrition causes obesity [51]. Increased body mass has been associated with decreased
transplantation and increased morbidity and mortality
[52].
Endocrine and Fertility Issues
Children with CKD often experience impairment of
pubertal growth and delayed sexual maturation. Delayed
puberty and reduced pubertal growth are most pronounced in children with preexisting severe stunting before puberty, requiring long-term dialysis treatment, and
in transplanted patients with poor graft function and
high glucocorticoid exposure. In pre-dialysis patients,
therapeutic measures to improve pubertal growth are
limited and mainly based on the preservation of kidney
function and the use of growth hormone treatment [53].
There may also be subsequent fertility issues. Many men
exhibit subfertility or infertility due to hypogonadism,
erectile dysfunction, direct impairment of spermatogenesis with sperm toxicity, and late-stage maturational arrest causing oligospermia or azoospermia [54]. Fertility
may improve post-kidney transplant, but not in all men.
Males with infantile cystinosis have hypergonadotropic
hypogonadism [55, 56], but testosterone replacement
may not always be safe [55]. For women with CKD, contraceptive side effects are more prevalent. CKD and its
therapies also affect future fertility. When conception is
desired, young women with CKD must plan meticulously because an ill-timed pregnancy can result in disease
688
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progression or flare. Certain immunosuppressants like
MMF and ACE inhibitors are potentially teratogenic [57,
58]. Among women with CKD, pregnancy risks are substantial, with up to 10-fold higher risk for preeclampsia
and 6-fold higher risk for preterm delivery [59, 60]. Pregnancy complications associated with inadequate placentation also increase maternal and newborn risks for cardiovascular morbidity/mortality and progression to kidney failure. As such, it is the obligation of every
nephrologist caring for women of reproductive age to
provide guidance in the choice of methods to prevent
unplanned pregnancies and to choose treatments that
preserve fertility [61].
Metabolic Acidosis, Metabolic Bone Disease, and
Growth Issues
Pediatric CKD patients often suffer from metabolic
acidosis, short stature (which in some cases may be due
to sodium wasting), hyperparathyroidism, and kidney
osteodystrophy. Short stature has multiple etiologies in
children with CKD/ESKD including genetic/syndromic factors, parental height, delayed puberty, abnormalities in the insulin-like growth factor, poor response to
natural growth hormone, water and electrolyte abnormalities (particularly sodium), prescribed steroids and
anemia [62]. Some diseases such as infantile cystinosis
cause profound short stature, which heavily impacts the
quality of life [63]. Growth hormone therapy is an effective treatment option, but physician and patient adherence is low due to a variety of reasons [64]. This is
despite the fact that growth hormone therapy in pediatric CKD patients has been demonstrated to improve
final height and it does not worsen the progression of
CKD nor is it associated with rejection after kidney
transplantation [65]. Males especially have a very low
quality of life with short stature, as was shown in a nationwide study comparing the quality of life of young
adults with pediatric cancer or CKD (see Fig. 2) [25, 66].
Patient factors (needle phobia), caregiver factors (low
focus on final height), and insurance coverage are major barriers for the prescription of recombinant human
growth hormone [67].
Surgical Issues of CKD/ESKD
These include urological procedures, vesicostomies,
gastrostomy tubes, dialysis access (peritoneal catheters,
central venous catheters, arteriovenous fistulas, or grafts),
and complications such as peritonitis infections, sepsis,
and thrombosis. Kidney transplant requires prolonged
hospitalization and carries infectious and thrombotic
Diaz-Gonzalez de Ferris et al.

Related to:
• Metabolic acidosis
• Metabolic bone disease
• Growth hormone resistance
• Chronic anemia
• Lack of health care/medication access
• Low treatment adherence
Affects life-long:
• Social life
• Health-related quality of life
Treatment:
• Regulate treatment of MBD, Acid-base
disorders and anemia
• Growth hormone – which does not
seem to accelerate progression to ESRD

Fig. 2. Short stature in pediatric-onset CKD or ESKD. ESKD, end-stage kidney disease.

risks. Parathyroidectomy and orthopedic procedures
may be needed for those with uncontrolled metabolic
bone disease.
Caregivers
Caregivers not only have to perform their parenting
duties but also must promote healthy family environments to allow the adaptation and to reduce frustration,
anxiety and grief as much as possible. Caregiver anxiety
is a major contributor to depression of the pediatric CKD
patient [22]. Additionally, challenges with parenting
skills affect how pediatric CKD patients grow up [23].
Caregivers may experience guilt and tendencies to spoil
the children and adolescents, rather than making them
responsible for their actions or delegating responsibilities
of health management. Parenting style matters: permissive or indulgent education leads to inability to be successful in the adult environment, authoritarian education
style yields best resilience in a competitive work environment, and authoritative education style leads to the best
transition readiness [68]. Caregivers play a significant
role in their child’s health knowledge and management of
their conditions (Table 2).
Caregiver’s level of role overload (a situation in which
the demands of an individual’s roles are beyond their capacity to perform adequately) has been associated with
poor outcomes in adolescents. We have demonstrated
that caregivers with high levels of role overload may perTransition to Adult-Focused Health care

ceive their youth as having lower self-management skills
and being less ready to transition to adult-focused care,
based on the parent STARx Questionnaire [69]. Our
group also has reported that adolescents prefer to learn
about their health condition from their parents followed
by their providers [68]. We also demonstrated that parents are at almost the same level of disease knowledge as
their child, based on the parent version of the TRxANSITION Index [70].
HCT Preparation and Self-Management

The process of HCT from pediatric- to adult-focused
services has been defined and endorsed by pediatricand adult-focused nephrology associations [71–73],
and models for research and clinical practice have been
proposed [74]. HCT preparation must take place both
in the pediatric- and adult-focused settings, particularly since the brain is not fully developed until about 25
years of age [75]. Adolescents who prefer to learn from
their parents have better adherence, while those who
prefer to learn about their health from health providers
have better self-efficacy and HCT preparation scores
[76]. Barriers and facilitators for HCT have started to
be identified in the literature and are discussed in Table 3, along with suggestions to overcome these barriers.
Blood Purif 2021;50:684–695
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Table 2. HCT and self-management: evidence from the literature and field work

Task/skill

Issue

Activity

HCT program

Unavailable or limited HCT program.
Unclear if these services are billable

Build a transition program in combination with the adult
center to improve care and awareness of the patients
following guidelines [72, 73]. Follow clinical framework
[74] and billing guide in www.gottransition.org

Tools to measure HCT readiness
in patient

Unclear about patient readiness

Use the provider-administered/verified TRxANSITION
Index [76], the self-administered STARx Questionnaire
[77, 78], or RTQ Survey [79]

Tools to measure HCT readiness
in parent/caregiver or provider

Unclear about parent/caregiver
Use the provider-administered/verified TRxANSITION
knowledge or their perception on their Index parent version [70], the self-administered STARx
child’s readiness
Questionnaire parent version, or RTQ Survey [79] or
provider survey [80]

AYA’s preferred person to learn
from about health condition

Parent is preferable source of health
information, followed by health
provider [75]

Measure [70] and understand parental knowledge about
their child´s disease as well as comfort teaching their
child about their health and treatment

Populations at risk for poor HCT Patients of underrepresented race/
readiness
ethnicities or lower socioeconomic
status [82]

Dedicate special time and resources to ensure equity and
patient safety

Self-management

Encourage patients to learn about their health condition,
medications, and dietary needs at an early age and
continue re-enforcement of these activities. Encourage
home chores by the child based on abilities. Determine
parenting style [68] and burden of care [69]. Encourage
parents to gradually delegate responsibilities to their
child [71]

Showing failure or success in
managing their disease from an
holistic perspective

HCT, health-care transition; AYA, adolescents and young adults.

Monitoring of HCT Readiness
Tools that measure HCT readiness and have been tested
in AYAs with CKD/ESKD are the TRxANSITION Index
[77], a provider-administered and verified measure and the
self-administered STARx Questionnaire [78, 79]. We have
also developed their parent-equivalent surveys (See www.
med.unc.edu/transition) [69]. There is another survey for
transplant patients (RTQ) [80, 81]. We administer the TRxANSITION Index and STARx Questionnaire annually.
With longitudinal observations of over 10 years, we have
documented that AYAs achieve self-management skills in
their mid-20s, based on the TRxANSITION Index [82].
Equity Issues
Language and cultural barriers among patients and
caregivers need to be considered. In a sample of AYAs
with chronic conditions who had public health insurance,
we demonstrated that those with a high rate of disease
self-management had more life-time emergency depart690
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ment visits, hospitalizations, and in-patient days compared to those with lower self-management skills [83]. In
some jurisdictions, chronological rather than developmental age determines the timing of transfer, which may
not be aligned with achieving optimal health outcomes.
Pediatric-Focused Specialty and Primary Care Teams
In many jurisdictions, HCT outcomes are poor and
may even involve graft loss or exacerbation of chronic
conditions, especially when sub-optimal HCT preparation takes place and patients get lost in the transfer from
a more paternalistic to a self-care-oriented approach. The
HCT process needs to be carefully planned and continued
in the adult-oriented health-care systems. Communication and close collaboration between the patients, caregivers, and primary care/specialty health providers is paramount. AYA patients with CKD/ESKD are particularly
challenging, as they need customized HCT preparation
based on developmental characteristics in a facility that
Diaz-Gonzalez de Ferris et al.

Table 3. Barriers and facilitators for HCT preparation based on the International and interdisciplinary HCT model [73]
Barriers

Facilitators

Patient
Anxiety

Acknowledge and discuss psychological support and refer to support groups when possible [22]

Depression

Antidepressants as indicated and refer to psychiatry/psychological care [21]

Risk behaviors/HRQoL/self-image

Acknowledge and discuss with patient
Refer for psychological support [23–25, 28–33]

Low literacy

Speak with all patients/families using plain language and low-literacy terms

Cognitive impairment/ADHD

Use cognitive remediations and treatment as needed [18]

Low academic achievement

Practice constant communication with educators, starting with a letter that describes the cognitive issues of CKD.
Request evaluation for an individualized education plan [20, 25]

Learning about their health condition
and diet

Use low-literacy patient education material and offer review discussion, particularly if diagnosis was at an early
age. Consider using the following kidney disease and transition education tools: https://www.med.unc.edu/
transition/transition-tools/

Caregiver
Caregiver anxiety

Acknowledge and discuss psychological support. Refer to support groups when possible

Caregiver depression

Have caregiver seek psychiatric/psychological care

Caregiver role overload

Provide strategies for the caregiver to effectively manage and delegate all duties [68]

Parenting style of the caregiver

Counsel on effective parenting styles [67]

Grief/guilt/catastrophizing

Continuously acknowledge these feelings from the time of diagnosis and provide coping strategies/community
resources. Refer to caregiver support groups when available

Caregiver low literacy

For all patients, regardless of education level, speak using plain language and low-literacy terms

Unwilling to “let go” of health
management

Use caregiver HCT readiness surveys [69]. Ask caregiver to start delegating responsibilities for home chores in
early childhood and health management starting in early adolescent years [27]

Caregiver as a resource for their child’s Discuss with caregiver that their child will most likely come to them for health-related questions [74]. Educate
health education
caregiver, offering review sessions
Consider using the following kidney disease and transition education tools: https://www.med.unc.edu/transition/
transition-tools
Providers
Why is having a HCT/self-management Given the poor outcomes of unprepared patients transferred to adult-focused services (e.g., death or loss of
preparation program a priority?
transplant), the International Society of Nephrology and the International Pediatric Nephrology Association have
identified HCT preparation as a priority for patient safety and quality improvement [27, 65, 70, 71, 72]
When to start and end HCT/selfmanagement preparation

Start as early as possible but if limited staff, start at age 15 [81]. The age to end this preparation is in the mid-20s,
as during this age, patients can self-manage their condition [80]

How to do HCT/self-management
preparation

Use HCT readiness surveys every 6–12 months to identify skills achieved and areas of deficits [75–78, 79] Train
patients based on age and cognitive level [19]

Where do HCT/self-management
preparation activities happen?

They can be done at the in-patient service or outpatient clinics
Brief interventions based on deficits and age are ideal, given attention span issues

Who does the HCT/self-management
training?

All health providers during all interactions with patients. This should be an interdisciplinary and coordinated
process [73]

Unfamiliarity with the transition
process and preparation

Learn about HCT [70–72] and develop a plan (see www.gottransition.org)
Use HCT tools to measure progress and skill acquisition every 6–12 months (see www.med.unc.edu/transition)

Low trust in the adult-focused health
system by the patient

Identify adult-focused primary care and specialty providers who are comfortable caring for AYAs with CKD/
ESRD

Poor interdisciplinary communication Utilize discharge letters and medical passports that the patients can carry with them
Personnel issues

Identify a HCT leader who ideally can serve as a bridge to all health systems

Billing issues (in the USA)

Develop a billing plan per Got Transition (see www.gottransition.org)

Transition to Adult-Focused Health care
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Table 3 (continued)
Barriers

Facilitators

System
Health insurance coverage

Maximize opportunities for funding when possible. Keep in mind that those with public or no insurance (USA)
are at a greater risk for low transition readiness

Pediatric hospital age-cap policies

Advocate for the care of AYAs with CKD/ESKD who have unique comorbidities and special needs, so that
chronological age does not determine access to pediatric care

Being from an underrepresented race
or ethnicity

Identify opportunities to optimize the outcomes of these at-risk populations. Use culturally sensitive resources

AYA, adolescents and young adults; HCT, health-care transition; HRQoL, health-related quality of life; ESKD, end-stage kidney disease.

will optimize their quality of life. While Internal Medicine/Pediatrics specialists are particularly qualified to
serve transitioning AYAs with chronic conditions, there
are not enough providers with this combined training.
Family practitioners and pediatric primary care providers
have the benefit of long-term relationships with families,
but they are also busy providers with short appointment
times. As the timing of transition may coincide with moving for post-secondary education, these resources may be
lost at the same time. Nonetheless, primary care providers
are uniquely suited to bridge some of the needs of AYA
patients during the transition period.
Table 3 depicts some of the facilitators and barriers of
HCT/self-management preparation as reported in the literature or based on our own longitudinal transition program, at the University of North Carolina Chapel Hill,
established in 2006 with collaborators in México (Hospital Infantil de México Federico Gómez), Colombia (Hospital Valle del Lili), and other countries around the world.
Important barriers of HCT preparation (e.g., finding
adult-focused practices that will accept these AYAs, negotiating the unfamiliar adult health-care system, and
poor communication between pediatric- and adult-focused providers or different electronic health record systems), can be addressed by a dedicated interdisciplinary
HCT team. The members of this HCT team need to help
the patient/family feel comfortable and confident for the
transfer to a new facility/team; however, the framework
for an effective HCT preparation remains to be validated.
Adult-Focused Team
Adult-focused nephrologists and primary care providers are not as familiar with the unique diagnoses/comorbidities of AYAs with pediatric-onset CKD/ESKD and
have less access to interdisciplinary collaborators/resources, compared to pediatric practices. In the USA,
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most pediatric nephrologists are in academic settings
with more access to ancillary health services and have
more flexibility to accept under-insured patients, whereas adult-focused nephrologists are in private practices
and have less flexibility in those aspects of care. In Table 3, we have listed the facilitators to help with the continued patient education and self-management services.
While not fully comprehensive, this table also lists some
of the “how to do” activities for HCT/self-management
preparation in clinical practice.
Conclusions

AYAs with CKD/ESKD have significant comorbidities
that require close interdisciplinary collaboration between
clinical, dental, psychological, and academic teams, in order to achieve successful patient and family outcomes.
Taken together, patients with pediatric-onset CKD/
ESKD transitioning to adult health care are not only going through a difficult phase of their development, but
may face substantial physical and psychological challenges. Those with a longer duration of CKD/ESKD or with
associated syndromes are at a greater risk for cognitive
impairment. Patients and caregivers may have additional
anxieties, as these families face significant financial challenges and burden of care. Providers need to know about
the patients’ development (cognitive abnormalities,
ADHD, delayed/shortened puberty, and growth failure),
in addition to age-related adherence issues, to address
disease-specific comorbidities. AYAs with CKD/ESKD
often feel out of place in the adult practice setting, due to
the great predominance of much older patients. All of
these challenges mandate a structured HCT preparation
program, starting in early adolescence and continuing in
the adult-focused setting, to improve patient outcomes.
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